Christian B. Jung, PhD, is a partner at SV Dementia Discovery Fund since September 2019, co-leading a major venture capital initiative focused on innovative therapeutics for dementia. In addition to this role, Christian serves on the boards of Amphista Therapeutics Limited, Harness Therapeutics, and LoQus23 Therapeutics Ltd. Previously, Christian held principal and board observer roles at multiple companies, including Wellington Partners Life Sciences, TRiCares GmbH, UroMems, and coramaze technologies GmbH, among others. Academic qualifications include a PhD in Medical Life Science and Technology, an MSc in Molecular Biotechnology, and additional studies in Cardiovascular Science and Pharmacology from prestigious institutions including the Technical University of Munich and The University of Queensland.